Tag: clinical trials
-
Collaboration Collecting Data to ID Precise Cancer Meds
7 April 2015. A partnership between Caris Life Sciences and COTA, short for Cancer Outcomes Tracking and Analysis, is combining data on the chemical makeup of cancer patients with clinical outcomes information to create better profiles of cancer tumors and identify more personalized therapies. Financial details between Caris Life Sciences in Irving, Texas and COTA,…
-
Astellas Getting First Access to Leukemia Antibody
3 April 2015. MD Anderson Cancer Center in Houston is granting Astellas Pharma Inc. in Tokyo an option to license MD Anderson’s discovery of a synthetic antibody showing promise as a treatment for acute myeloid leukemia. For the licensing option, MD Anderson could earn up to $26 million in fees and research funding. Acute myeloid…
-
Intermediate Trial Shows Ebola Vaccines Safe
27 March 2015. An intermediate-stage clinical trial in Liberia testing two new vaccines to prevent Ebola infections, shows the vaccines appear to be safe, allowing for larger-scale assessments. Initial results of the trial were reported yesterday by National Institute of Allergy and Infectious Diseases (NIAID), part of National Institutes of Health. The 2014-15 Ebola virus…
-
FDA Approves Inhalational Anthrax Treatment
25 March 2015. The U.S. Food and Drug Administration today approved a treatment for inhalational anthrax, a rare but dangerous respiratory condition that can result from a bioterrorist attack. The drug is marketed as Anthrasil by Emergent BioSolutions Inc. in Gaithersburg, Maryland. Anthrax is caused by Bacillus anthracis, bacteria found naturally in soil and commonly…
-
Clinical Trial to Test Ketamine to Treat Rett Syndrome
23 March 2015. A clinical trial is planned to test an anesthetic used in surgery as a treatment for Rett syndrome, a rare developmental disorder affecting girls. The trial testing the anesthetic ketamine will be conducted by Case Western Reserve University medical school in Cleveland, funded by a $1.3 million grant from Rett Syndrome Research Trust.…
-
Lilly Acquiring Treatment for Autoimmune Disorders
19 March 2015. The pharmaceutical company Eli Lilly and Company is acquiring from Hanmi Pharmaceutical, an experimental drug that blocks the actions of an enzyme associated with rheumatoid arthritis and other autoimmune diseases. The deal can pay Hanmi, in Seoul, Korea, as much as $690 million. Autoimmune disorders are diseases where the body’s immune system…
-
U.K. Govt, Pharmas Form Dementia Research Fund
17 March 2015. A coalition of the United Kingdom government, five pharmaceutical companies, and the foundation Alzheimer’s Research UK are creating a $100 million fund to finance early research into treatments and cures for dementia. The U.K. health minister Jeremy Hunt is scheduled to unveil the Dementia Discovery Fund at a World Health Organization meeting…
-
Device Shown to Reduce Stroke in Heart Valve Replacements
16 March 2015. First results from a clinical trial in Europe and Israel show an experimental mesh device deployed during heart valve replacement surgery sharply reduces strokes and cognitive damage, complications associated with the procedure. A team from Yale University School of Medicine presented its findings yesterday of the study testing TriGuard, made by Keystone…
-
Campaign Seeks More Minorities in Brain Disorder Trials
13 March 2015. A new public service campaign led by former actress and restaurateur B. Smith aims to recruit more minorities in clinical trials for brain disorders, such Alzheimer’s disease, from which Smith suffers. Smith and her husband Dan Gasby are partnering in the campaign with Brain Health Registry, affiliated with University of California in…
-
Stem Cells Shown to Stop Decline for Some ALS Patients
13 March 2015. An intermediate-stage clinical trial of a stem cell therapy to treat amyotrophic lateral sclerosis, or ALS, shows some patients receiving the treatments nearly stopped the decline or improved their muscle functions. Neuralstem Inc., a biotechnology company in Germantown, Maryland sponsoring the study, reported summary results yesterday. ALS, also known as Lou Gehrig’s…